NCEL
NewcelXยทNASDAQ
--
--(--)
--
--(--)
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About NCEL
Newcelx Ltd.
A clinical-stage biopharmaceutical company that developing innovative therapies for rare and complex central nervous system disorders
The Circle 6, 8058 Zurich, Switzerland
--
NewcelX Ltd., was established in June 2015. The company is an innovative biopharmaceutical company dedicated to the discovery and development of life-enhancing drug therapies for rare central nervous system diseases.
Company Financials
EPS
NCEL has released its 2021 Q1 earnings. EPS was reported at -0.41, versus the expected 0, missing expectations. The chart below visualizes how NCEL has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
You can ask Aime
No Data
